Asim Sayed, DPM
Podiatrist · Blue Springs, MONPI 1801329925
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,936 of the $4,284 with a category attached, or 68.5%. 22 manufacturers reported payments, led by Stryker at 45.6% of the total. Reporting peaked in 2024 at $1,249 and has fallen 58.3% since, to $521 in 2025.
Across 78 payments — averaging $54.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Southern Edge Orthopaedics, Inc.$937
- Treace Medical Concepts, Inc.$353
- Kerecis Limited$198
- Smith+Nephew$164
- AbbVie$111
- plus $566 from 16 others
What the payments were for
- Travel & lodging$41110%
- Food & beverage$2,93669%
- Education$93722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 39 | $1,954 |
| Southern Edge Orthopaedics, Inc. | 1 | $937 |
| Treace Medical Concepts, Inc. | 5 | $353 |
| Kerecis Limited | 2 | $198 |
| Smith+Nephew | 5 | $164 |
| AbbVie(2 entities) | 6 | $111 |
| Angiodynamics, Inc. | 1 | $104 |
| Abbott | 1 | $77 |
| Convatec Inc. | 4 | $75 |
| Nevro Corp. | 2 | $46 |
| Acumed LLC | 1 | $42 |
| Polynovo North America LLC | 1 | $25 |
| Biocomposites Inc | 1 | $24 |
| Averitas Pharma Inc. | 1 | $24 |
| Flower Orthopedics Coporation | 1 | $23 |
| Next Science LLC | 1 | $22 |
| Acera Surgical, Inc. | 1 | $21 |
| Titan Surgical Group, LLC | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Solventum Corporation | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,284 in reported general payments places this provider in the 75th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 12 | $301 |
| Gabapentin | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Blue Springs
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
- Ellen ColganWarrenton$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.